Durvalumab,Tremelimumab
AstraZeneca
 just presented at #wcgic2022 post hoc analysis on liver function in himalaya #hcc trial 50% of pts in cpa are albi1 vs albi2 liver function has strong prognostic impact confirmed activity of stride in albi1 and 2/3 #livertwitter #immunotherapy 
Physician-scientist, focussed on translational research in hepatobiliary cancer and precision medicine